Oral Health Assessment in Adolescents with End-Stage Chronic Kidney Disease
Abstract
1. Introduction
2. Materials and Methods
2.1. Subjects
2.2. Study Design
2.3. Ethical Review
2.4. Inclusion Criteria and Exclusion Criteria
2.5. Oral Health Analysis
2.6. Chemical Analysis
2.7. Microbiological Analysis
- -
- Grade 1 corresponded to a normal state of oral microbiota;
- -
- Grade 2 indicated a dysbiotic shift characterized by the predominance of a single opportunistic microorganism with the preservation of normal microbial species in oral microbiota;
- -
- Grade 3 (grade I–II dysbiosis) represented a subcompensated form with more pronounced alterations in microbial composition, including two or three pathogenic species accompanied by a partial reduction in normal microbiota;
- -
- Grade 4 (grade II–III dysbiosis) was defined by the detection of a pathogenic monoculture with a marked decrease or complete absence of representatives of the normal microbiota;
- -
- Grade 5 (grade IV dysbiosis) was characterized by the presence of pathogenic bacterial associations with a marked increase in yeast-like fungi.
2.8. Immunological Analysis
2.9. Statistical Analysis
3. Results
3.1. Oral Health Status
3.2. Oral Microflora in ESKD Adolescents
3.3. Immunological Status
3.4. Correlation Analysis of Oral Microbiota and Biomarkers
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
| CKD | Chronic kidney |
| ESKD | End-stage chronic kidney disease |
| GCF | Gingival crevicular fluid |
| IL-1β | Interleukin-1β |
| IL-8 | Interleukin-8 |
| TNF-α | Tumor necrosis factor alpha |
| VEGF | Vascular endothelial growth factor |
| sIgA | Secretory immunoglobulin A |
| TAC | Total antioxidant capacity |
| DMFT | Decayed, missed, filled teeth index |
| OHI-S | Oral hygiene index-simplified |
| PMA | Papillary marginal attached index |
| PI | Periodontal index |
| PCR | Polymerase chain reaction |
| ELISA | Enzyme-linked immunosorbent assay |
References
- Stevens, P.E.; Ahmed, S.B.; Carrero, J.J.; Foster, B.; Francis, A.; Hall, R.K.; Herrington, W.G.; Hill, G.; Inker, L.A.; Kazancıoğlu, R.; et al. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024, 105, S117–S314. [Google Scholar] [CrossRef]
- Harambat, J.; Van Stralen, K.J.; Kim, J.J.; Tizard, E.J. Epidemiology of Chronic Kidney Disease in Children. Pediatr. Nephrol. 2012, 27, 363–373. [Google Scholar] [CrossRef] [PubMed]
- Hill, N.R.; Fatoba, S.T.; Oke, J.L.; Hirst, J.A.; O’Callaghan, C.A.; Lasserson, D.S.; Hobbs, F.D.R. Global Prevalence of Chronic Kidney Disease—A Systematic Review and Meta-Analysis. PLoS ONE 2016, 11, e0158765. [Google Scholar] [CrossRef]
- Laheij, A.; Rooijers, W.; Bidar, L.; Haidari, L.; Neradova, A.; De Vries, R.; Rozema, F. Oral Health in Patients with End-Stage Renal Disease: A Scoping Review. Clin. Exp. Dent. Res. 2022, 8, 54–67. [Google Scholar] [CrossRef]
- Velan, E.; Sheller, B. Oral Health in Children with Chronic Kidney Disease. Pediatr. Nephrol. 2021, 36, 3067–3075. [Google Scholar] [CrossRef]
- Costantinides, F.; Castronovo, G.; Vettori, E.; Frattini, C.; Artero, M.L.; Bevilacqua, L.; Berton, F.; Nicolin, V.; Di Lenarda, R. Dental Care for Patients with End-Stage Renal Disease and Undergoing Hemodialysis. Int. J. Dent. 2018, 2018, 9610892. [Google Scholar] [CrossRef] [PubMed]
- Elhusseiny, G.A.; Saleh, W. Oral Health in Children with Chronic Kidney Disease, Hemodialysis, and Renal Transplantation: A Comprehensive Narrative Review of the Oral Manifestations and Dental Implications. Clin. Med. Insights Pediatr. 2024, 18, 11795565241271689. [Google Scholar] [CrossRef] [PubMed]
- Tuma, M.; Silva Andrade, N.; Correia Aires, R.; Cristelli, M.P.; Medina Pestana, J.O.; Gallottini, M. Oral Findings in Kidney Transplant Children and Adolescents. Int. J. Paediatr. Dent. 2022, 32, 894–902. [Google Scholar] [CrossRef]
- Höfer, K.; Turnowsky, A.; Ehren, R.; Taylan, C.; Plum, G.; Witte, H.; Noack, M.J.; Weber, L.T. The Impact of a Needs-Oriented Dental Prophylaxis Program on Bacteremia after Toothbrushing and Systemic Inflammation in Children, Adolescents, and Young Adults with Chronic Kidney Disease. Pediatr. Nephrol. 2022, 37, 403–414. [Google Scholar] [CrossRef]
- Nanda, T.; Singh, B.; Sharma, P.; Arora, K.S. Cyclosporine A and Amlodipine Induced Gingival Overgrowth in a Kidney Transplant Recipient: Case Presentation with Literature Review. BMJ Case Rep. 2019, 12, e229587. [Google Scholar] [CrossRef]
- Hu, J.; Iragavarapu, S.; Nadkarni, G.N.; Huang, R.; Erazo, M.; Bao, X.; Verghese, D.; Coca, S.; Ahmed, M.K.; Peter, I. Location-Specific Oral Microbiome Possesses Features Associated With CKD. Kidney Int. Rep. 2018, 3, 193–204. [Google Scholar] [CrossRef]
- Campbell, P.M.; Humphreys, G.J.; Summers, A.M.; Konkel, J.E.; Knight, C.G.; Augustine, T.; McBain, A.J. Does the Microbiome Affect the Outcome of Renal Transplantation? Front. Cell. Infect. Microbiol. 2020, 10, 558644. [Google Scholar] [CrossRef]
- Hoefer, K.C.; Weber, L.T.; Barbe, A.G.; Graf, I.; Thom, S.; Nowag, A.; Scholz, C.J.; Wisplinghoff, H.; Noack, M.J.; Jazmati, N. The Tongue Microbiome of Young Patients with Chronic Kidney Disease and Their Healthy Mothers. Clin. Oral Investig. 2024, 28, 110. [Google Scholar] [CrossRef] [PubMed]
- Nam, Y.; Kim, Y.-Y.; Chang, J.-Y.; Kho, H.-S. Salivary Biomarkers of Inflammation and Oxidative Stress in Healthy Adults. Arch. Oral Biol. 2019, 97, 215–222. [Google Scholar] [CrossRef]
- Ertugrul, A.S.; Sahin, H.; Dikilitas, A.; Alpaslan, N.; Bozoglan, A. Comparison of CCL28, Interleukin-8, Interleukin-1β and Tumor Necrosis Factor-alpha in Subjects with Gingivitis, Chronic Periodontitis and Generalized Aggressive Periodontitis. J. Periodontal Res. 2013, 48, 44–51. [Google Scholar] [CrossRef]
- Carrillo-López, N.; Martínez-Arias, L.; Fernández-Villabrille, S.; Ruiz-Torres, M.P.; Dusso, A.; Cannata-Andía, J.B.; Naves-Díaz, M.; Panizo, S.; on behalf of the European Renal Osteodystrophy (EUROD) Workgroup. Role of the RANK/RANKL/OPG and Wnt/β-Catenin Systems in CKD Bone and Cardiovascular Disorders. Calcif. Tissue Int. 2021, 108, 439–451. [Google Scholar] [CrossRef]
- Patel, S.A.; Nilsson, M.B.; Le, X.; Cascone, T.; Jain, R.K.; Heymach, J.V. Molecular Mechanisms and Future Implications of VEGF/VEGFR in Cancer Therapy. Clin. Cancer Res. 2023, 29, 30–39. [Google Scholar] [CrossRef]
- Brodzikowska, A.; Kochańska, B.; Bogusławska-Kapała, A.; Strużycka, I.; Górski, B.; Miskiewicz, A. Assessment of the Salivary Concentrations of Selected Immunological Components in Adult Patients in the Late Period after Allogeneic Hematopoietic Stem Cell Transplantation-A Translational Study. Int. J. Mol. Sci. 2024, 25, 1457. [Google Scholar] [CrossRef]
- Kwiatkowska, M.; Oldakowska-Jedynak, U.; Wojtaszek, E.; Glogowski, T.; Malyszko, J. Potential Effects of Immunosuppression on Oxidative Stress and Atherosclerosis in Kidney Transplant Recipients. Oxidative Med. Cell. Longev. 2021, 2021, 6660846. [Google Scholar] [CrossRef] [PubMed]
- Kodaman Dokumacıgil, N.; Sezer, B.; Oktay, Ş.; Alpay, H.; Kargül, B. Dental Caries, Oral Hygiene and Salivary Characteristics in Children with Chronic Kidney Disease: A Case–Control Study. Pediatr. Nephrol. 2025, 40, 2627–2637. [Google Scholar] [CrossRef] [PubMed]
- Mass Spectrometry. In Principles and Applications of Clinical Mass Spectrometry; Elsevier: Amsterdam, The Netherlands, 2018; pp. 33–65.
- Perepelova, T.; Faustova, M.; Dvornyk, V.; Dobrovolskyi, O.; Koval, Y.; Loban, G. The Level of Dysbiosis of the Oral Cavity Depends on the Type of Dental Prosthesis of the Patient. Bratisl. Lek. Listy 2023, 124, 599–603. [Google Scholar] [CrossRef]
- Fernandes, G.V.O.; Mosley, G.A.; Ross, W.; Dagher, A.; Martins, B.G.d.S.; Fernandes, J.C.H. Revisiting Socransky’s Complexes: A Review Suggesting Updated New Bacterial Clusters (GF-MoR Complexes) for Periodontal and Peri-Implant Diseases and Conditions. Microorganisms 2024, 12, 2214. [Google Scholar] [CrossRef]
- Pakpour, A.H.; Kumar, S.; Fridlund, B.; Zimmer, S. A Case-Control Study on Oral Health-Related Quality of Life in Kidney Disease Patients Undergoing Haemodialysis. Clin. Oral Investig. 2015, 19, 1235–1243. [Google Scholar] [CrossRef] [PubMed]
- Yue, Q.; Yin, F.-T.; Zhang, Q.; Yuan, C.; Ye, M.-Y.; Wang, X.-L.; Li, J.-J.; Gan, Y.-H. Carious Status and Supragingival Plaque Microbiota in Hemodialysis Patients. PLoS ONE 2018, 13, e0204674. [Google Scholar] [CrossRef] [PubMed]
- Sezer, B.; Kaya, R.; Kodaman Dokumacıgil, N.; Sıddıkoğlu, D.; Güven, S.; Yıldız, N.; Alpay, H.; Kargül, B. Assessment of the Oral Health Status of Children with Chronic Kidney Disease. Pediatr. Nephrol. 2023, 38, 269–277. [Google Scholar] [CrossRef]
- Menezes, C.R.; Pereira, A.L.; Ribeiro, C.C.; Chaves, C.O.; Guerra, R.N.; Thomaz, É.B.; Monteiro-Neto, V.; Alves, C.M. Is there Association Between Chronic Kidney Disease and Dental Caries? A Case-Controlled Study. Med. Oral Patol. Oral Cir. Bucal 2019, 24, e211–e216. [Google Scholar] [CrossRef]
- Beyer, A.; Ebach, F.; Reutter, H.; Sauerstein, K.; Hilger, A.C.; Krickau, T.; Tzschoppe, A.; Woelfe, J.; Galiano, M.; Schaefer, J.T. Oral Health Status in Children with Chronic Kidney Disease, Kidney Transplantation, and Nephrotic Syndrome: A Cross-Sectional Study. Pediatr. Nephrol. 2025, 40, 2287–2293. [Google Scholar] [CrossRef]
- Costacurta, M.; Di Lauro, M.; Cornali, K.; Docimo, R.; Noce, A. Developmental Defects of Enamel and Dental Caries in Pediatric Patients with Chronic Kidney Disease–Mineral Bone Disorders. Appl. Sci. 2025, 15, 1164. [Google Scholar] [CrossRef]
- Shaikh, H.; Shilpa, R.H.; Fatima, A.; Asawa, K.; Kannan, K.; Lankar, A. Assessment of Oral Health-Related Quality of Life among Expatriate Working Population, Saudi Arabia: A Cross-Sectional Study. J. Int. Soc. Prev. Community Dent. 2020, 10, 504–510. [Google Scholar] [CrossRef]
- Dhingra, K.; Vandana, K.L. Indices for Measuring Periodontitis: A Literature Review. Int. Dent. J. 2020, 61, 76–84. [Google Scholar] [CrossRef]
- Sezer, B.; Kodaman Dokumacıgil, N.; Kaya, R.; Güven, S.; Türkkan, Ö.N.; Çiçek, N.; Alpay, H.; Kargül, B. Association Between Serum Biomarkers and Oral Health Status in Children with Chronic Kidney Disease: A Cross-Sectional Study. Clin. Oral Investig. 2023, 27, 3731–3740. [Google Scholar] [CrossRef]
- Silva, T.M.C.; Alves, L.A.C.; Garrido, D.; Watanabe, A.; Mendes, F.M.; Ciamponi, A.L. Health and Oral Health-Related Quality of Life of Children and Adolescents with Chronic Kidney Disease: A Cross-Sectional Study. Qual. Life Res. Int. J. Qual. Life Asp. Treat. Care Rehabil. 2019, 28, 2481–2489. [Google Scholar] [CrossRef] [PubMed]
- Zhang, R.; Wu, J.; Zhu, J.; Wang, X.; Song, J. Bibliometric Analysis of Research Trends and Characteristics of Drug-Induced Gingival Overgrowth. Front. Public Health 2022, 10, 979861. [Google Scholar] [CrossRef] [PubMed]
- Hickey, N.A.; Shalamanova, L.; Whitehead, K.A.; Dempsey-Hibbert, N.; van der Gast, C.; Taylor, R.L. Exploring the Putative Interactions Between Chronic Kidney Disease and Chronic Periodontitis. Crit. Rev. Microbiol. 2020, 46, 61–77. [Google Scholar] [CrossRef]
- Sedghi, L.; DiMassa, V.; Harrington, A.; Lynch, S.V.; Kapila, Y.L. The Oral Microbiome: Role of Key Organisms and Complex Networks in Oral Health and Disease. Periodontol. 2000 2021, 87, 107–131. [Google Scholar] [CrossRef]
- Pei, X.-M.; Zhou, L.-X.; Tsang, M.-W.; Tai, W.C.-S.; Wong, S.-C.C. The Oral Microbial Ecosystem in Age-Related Xerostomia: A Critical Review. Int. J. Mol. Sci. 2024, 25, 12815. [Google Scholar] [CrossRef] [PubMed]
- Leite de Oliveira Rosa, I.; de Oliveira Ferreira, E.; Vieira Colombo, A.P. Molecular Detection of Toxigenic Clostridioides Difficile in Subgingival Biofilm of Severe Periodontitis. Anaerobe 2025, 93, 102955. [Google Scholar] [CrossRef]
- Shiba, T.; Komatsu, K.; Sudo, T.; Sawafuji, R.; Saso, A.; Ueda, S.; Watanabe, T.; Nemoto, T.; Kano, C.; Nagai, T.; et al. Comparison of Periodontal Bacteria of Edo and Modern Periods Using Novel Diagnostic Approach for Periodontitis With Micro-CT. Front. Cell. Infect. Microbiol. 2021, 11, 723821. [Google Scholar] [CrossRef]
- Yetmar, Z.A.; Marty, P.K.; Clement, J.; Miranda, C.; Wengenack, N.L.; Beam, E. State-of-the-Art Review: Modern Approach to Nocardiosis-Diagnosis, Management, and Uncertainties. Clin. Infect. Dis. 2025, 80, e53–e64. [Google Scholar] [CrossRef]
- Ranganath, N.; Mendoza, M.A.; Stevens, R.; Kind, D.; Wengenack, N.; Shah, A. Rhodococcus Infection: A 10-Year Retrospective Analysis of Clinical Experience and Antimicrobial Susceptibility Profile. J. Clin. Microbiol. 2024, 62, e01537-23. [Google Scholar] [CrossRef]
- Chmielewski, M.; Załachowska, O.; Komandera, D.; Albert, A.; Wierzbowska, M.; Kwapisz, E.; Katkowska, M.; Gębska, A.; Garbacz, K. The Oral Cavity—Another Reservoir of Antimicrobial-Resistant Staphylococcus aureus? Antibiotics 2024, 13, 649. [Google Scholar] [CrossRef] [PubMed]
- Campos, J.; Pires, M.F.; Sousa, M.; Campos, C.; da Costa, C.F.F.A.; Sampaio-Maia, B. Unveiling the Relevance of the Oral Cavity as a Staphylococcus Aureus Colonization Site and Potential Source of Antimicrobial Resistance. Pathogens 2023, 12, 765. [Google Scholar] [CrossRef]
- Mohamed, M.E.; Saqr, A.; Staley, C.; Onyeaghala, G.; Teigen, L.; Dorr, C.R.; Remmel, R.P.; Guan, W.; Oetting, W.S.; Matas, A.J.; et al. Pharmacomicrobiomics: Immunosuppressive Drugs and Microbiome Interactions in Transplantation. Transplantation 2024, 108, 1895–1910. [Google Scholar] [CrossRef]
- Hajishengallis, G.; Lamont, R.J. Polymicrobial Communities in Periodontal Disease: Their Quasi-Organismal Nature and Dialogue with the Host. Periodontol. 2000 2021, 86, 210–230. [Google Scholar] [CrossRef]
- Sakanaka, A.; Kuboniwa, M.; Shimma, S.; Alghamdi, S.A.; Mayumi, S.; Lamont, R.J.; Fukusaki, E.; Amano, A. Fusobacterium Nucleatum Metabolically Integrates Commensals and Pathogens in Oral Biofilms. mSystems 2022, 7, e0017022. [Google Scholar] [CrossRef]
- Baciu, S.F.; Mesaroș, A.-Ș.; Kacso, I.M. Chronic Kidney Disease and Periodontitis Interplay—A Narrative Review. Int. J. Environ. Res. Public Health 2023, 20, 1298. [Google Scholar] [CrossRef]
- Lu, H.; Wu, H.; Yang, Y.; Feng, X.; Ma, X.; Xie, Y.; Xie, D.; Wang, W.; Lo, E.C.M.; Ye, W. Relationship Between Chronic Periodontitis and Inflammatory Cytokines in Patients Undergoing Maintenance Hemodialysis. Clin. Oral Investig. 2022, 26, 6699–6709. [Google Scholar] [CrossRef]
- Sylenko, H.M.; Skrypnykov, P.M.; Sylenko, Y.I.; Pisarenko, O.A. Features of development of generalized periodontitis in persons with secretory immunoglobulin a deficiency and its treatment (literature review). Wiad. Lek. 2021, 74, 1510–1514. [Google Scholar] [CrossRef] [PubMed]
- Abe, K.; Takahashi, A.; Fujita, M.; Imaizumi, H.; Hayashi, M.; Okai, K.; Ohira, H. Dysbiosis of Oral Microbiota and Its Association with Salivary Immunological Biomarkers in Autoimmune Liver Disease. PLoS ONE 2018, 13, e0198757. [Google Scholar] [CrossRef] [PubMed]
- Džunková, M.; Martinez-Martinez, D.; Gardlík, R.; Behuliak, M.; Janšáková, K.; Jiménez, N.; Vázquez-Castellanos, J.F.; Martí, J.M.; D’Auria, G.; Bandara, H.M.H.N.; et al. Oxidative Stress in the Oral Cavity Is Driven by Individual-Specific Bacterial Communities. NPJ Biofilms Microbiomes 2018, 4, 29. [Google Scholar] [CrossRef]
- Li, L.; Zhang, Y.-L.; Liu, X.-Y.; Meng, X.; Zhao, R.-Q.; Ou, L.-L.; Li, B.-Z.; Xing, T. Periodontitis Exacerbates and Promotes the Progression of Chronic Kidney Disease Through Oral Flora, Cytokines, and Oxidative Stress. Front. Microbiol. 2021, 12, 656372. [Google Scholar] [CrossRef]
- Mahendra, J.; Palathingal, P.; Mahendra, L.; Alzahrani, K.J.; Banjer, H.J.; Alsharif, K.F.; Halawani, I.F.; Muralidharan, J.; Annamalai, P.T.; Verma, S.S.; et al. Impact of Red Complex Bacteria and TNF-α Levels on the Diabetic and Renal Status of Chronic Kidney Disease Patients in the Presence and Absence of Periodontitis. Biology 2022, 11, 451. [Google Scholar] [CrossRef] [PubMed]
- Mazurek-Mochol, M.; Łagocka, R.; Dembowska, E.; Kozak, M.; Sawczuk, M.; Maciejewska, A.; Malinowski, D.; Safranow, K.; Pawlik, A. Lack of Association Between the VEGFA Gene Rs699947 Polymorphism and Periodontal Disease. Oral Health Prev. Dent. 2020, 18, 171–175. [Google Scholar] [CrossRef] [PubMed]
- Almerich-Silla, J.M.; Montiel-Company, J.M.; Pastor, S.; Serrano, F.; Puig-Silla, M.; Dasí, F. Oxidative Stress Parameters in Saliva and Its Association with Periodontal Disease and Types of Bacteria. Dis. Markers 2015, 2015, 653537. [Google Scholar] [CrossRef] [PubMed]






| Variable | Groups | p-Value | ||
|---|---|---|---|---|
| Group 1 (n = 30) | Group 2 (n = 20) | |||
| Age, mean ± SD (years) | 13.4 ± 1.8 | 13.7 ± 1.9 | 0.58 1 | |
| Median age (years) | 13 | 13 | – | |
| Age range (min–max), years | 12–17 | 12–17 | – | |
| Female, n (%) | 9 (30%) | 4 (20%) | 0.52 2 | |
| Toothbrushing frequency, n (%) | Once a day | 19 (63.3%) | 13 (65.0%) | 1.000 2 |
| Twice or more | 11 (36.7%) | 7 (35.0%) | ||
| Dental flossing using, n (%) | No | 27 (90.0%) | 18 (90.0%) | 1.000 2 |
| Yes | 3 (10.0%) | 2 (10.0%) | ||
| Variable | Groups | p-Value | |
|---|---|---|---|
| Group 1 (n = 30) | Group 2 (n = 20) | ||
| DMFT | 1.27 ± 2.12 | 1.6 ± 1.45 | >0.05 |
| OHI-S | 1.93 ± 0.76 | 1.01 ± 0.31 | <0.0001 |
| PMA, % | 31.97 ± 16.15 | 15.20 ± 8.04 | <0.0001 |
| PI | 2.32 ± 1.30 | 1.04 ± 0.43 | <0.0001 |
| pH | 7.34 ± 0.66 | 6.27 ± 0.64 | <0.0001 |
| Pathogen | Groups | p-Value | |
|---|---|---|---|
| Group 1 (n = 30) | Group 2 (n = 20) | ||
| Actinomyces spp. (median × 105), CFU/mL | 451 | 100 | >0.05 |
| Bifidobacterium spp. (median × 105), CFU/mL | 1539 | 710 | <0.05 * |
| Clostridium difficile (median × 105), CFU/mL | 355 | 204 | <0.05 * |
| Eubacterium spp. (median × 105), CFU/mL | 8693 | 4935 | >0.05 |
| Nocardia asteroids (median × 105), CFU/mL | 1943 | 184 | <0.05 * |
| Pseudonocardia spp. (median × 105), CFU/mL | 379 | 76 | >0.05 |
| Rhodococcus spp. (median × 105), CFU/mL | 976 | 521 | <0.05 * |
| Staphylococcus aureus (median × 105), CFU/mL | 1445 | 401 | <0.05 * |
| Streptococcus mutans (median × 105), CFU/mL | 1465 | 1038 | >0.05 |
| Alcaligenes spp. (median × 105), CFU/mL | 352 | 43 | <0.05 * |
| Streptococcus pneumonia (median × 105), CFU/mL | 189 | 70 | >0.05 |
| Candida spp. (median × 105), CFU/mL | 5492 | 1864 | <0.05 * |
| Aspergillus spp. (median × 105), CFU/mL | 4484 | 3324 | >0.05 |
| Eggerthella ribbon (median × 105), CFU/mL | 1160 | 440 | <0.05 * |
| Ruminococcus spp. (median × 105), CFU/mL | 521 | 370 | >0.05 |
| Propionibacterium freudenreichii (median × 105), CFU/mL | 2378 | 1847 | >0.05 |
| Grade | Groups | p-Value | |
|---|---|---|---|
| Group 1 (n = 30) | Group 2 (n = 20) | ||
| Grade 1, n (%) | 0 (0.0%) | 8 (40.0%) | <0.0001 ** |
| Grade 2, n (%) | 0 (0.0%) | 11 (55.0%) | <0.0001 ** |
| Grade 3, n (%) | 9 (30.0%) | 1 (5.0%) | <0.05 * |
| Grade 4, n (%) | 14 (46.7%) | 0 (0.0%) | <0.0001 ** |
| Grade 5, n (%) | 7 (23.3%) | 0 (0.0%) | <0.05 * |
| Periodontopathogenic Bacteria | Groups | p-Value | |
|---|---|---|---|
| Group 1 (n = 30) | Group 2 (n = 20) | ||
| Aggregatibacter actinomycetemcomitans, % | 23 | - | <0.05 * |
| Fusobacterium nucleatum, % | 100 | 100 | >0.05 |
| Prevotella intermedia, % | 13 | - | >0.05 |
| Treponema denticola, % | 10 | - | >0.05 |
| Tannerella forsythia, % | 77 | - | <0.001 ** |
| Porphyromonas gingivalis, % | 10 | - | >0.05 |
| Biomarker | Correlation Coefficient Value * | |||||||
|---|---|---|---|---|---|---|---|---|
| Fusobacterium nucleatum | Tannerella forsythia | Treponema denticola | Aggregatibacter actinomycetemcomitans | Prevotella intermedia | Porphyromonas gingivalis | Oral Microbiota Composition | ||
| Saliva | VEGF, pg/mL | — | +0.380 ** | −0.066 | +0.358 ** | +0.169 | +0.167 | +0.543 ** |
| TNF-α, pg/mL | — | +0.242 | −0.104 | +0.052 | −0.018 | +0.478 ** | +0.418 ** | |
| IL-1β, pg/mL | — | +0.445 ** | −0.159 | +0.407 ** | −0.109 | +0.315 ** | +0.365 ** | |
| IL-8, pg/mL | — | +0.256 | −0.110 | +0.216 | −0.075 | +0.124 | +0.210 | |
| sIgA, mg/L | — | −0.064 | −0.184 | −0.029 | +0.220 | −0.093 | −0.249 | |
| TAC, mmol/L | — | −0.658 ** | −0.237 | −0.245 | −0.262 | −0.165 | −0.753 ** | |
| GCF | VEGF, pg/mL | — | −0.574 ** | −0.295 ** | −0.153 | −0.054 | −0.140 | −0.670 ** |
| TNF-α, pg/mL | — | −0.537 ** | −0.112 | −0.249 | −0.125 | −0.125 | −0.523 ** | |
| IL-1β, pg/mL | — | +0.347 ** | +0.097 | +0.139 | +0.136 | +0.299 ** | +0.327 ** | |
| IL-8, pg/mL | — | −0.600 ** | −0.165 | −0.267 | −0.177 | −0.123 | −0.632 ** | |
| sIgA, mg/L | — | −0.097 | −0.167 | +0.126 | +0.209 | −0.055 | +0.013 | |
| TAC, mmol/L | — | −0.578 ** | −0.180 | −0.243 | −0.193 | −0.171 | −0.384 ** | |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Morozova, N.S.; Maslikova, E.A.; Elovskaya, A.A.; Nesterova, O.V.; Allahverdiyev, A.F.; Dikopova, N.Z.; Volkov, A.G.; Sergeyev, O.V.; Velichko, E.V.; Maltseva, L.D.; et al. Oral Health Assessment in Adolescents with End-Stage Chronic Kidney Disease. J. Clin. Med. 2026, 15, 165. https://doi.org/10.3390/jcm15010165
Morozova NS, Maslikova EA, Elovskaya AA, Nesterova OV, Allahverdiyev AF, Dikopova NZ, Volkov AG, Sergeyev OV, Velichko EV, Maltseva LD, et al. Oral Health Assessment in Adolescents with End-Stage Chronic Kidney Disease. Journal of Clinical Medicine. 2026; 15(1):165. https://doi.org/10.3390/jcm15010165
Chicago/Turabian StyleMorozova, Natalia Sergeevna, Ekaterina Andreevna Maslikova, Alina Alekseevna Elovskaya, Olga Vladimirovna Nesterova, Arif Fuad Allahverdiyev, Natalya Zhorzhevna Dikopova, Alexander Grigorievich Volkov, Oleg Vitalievich Sergeyev, Ellina Valerievna Velichko, Larisa Dmitrievna Maltseva, and et al. 2026. "Oral Health Assessment in Adolescents with End-Stage Chronic Kidney Disease" Journal of Clinical Medicine 15, no. 1: 165. https://doi.org/10.3390/jcm15010165
APA StyleMorozova, N. S., Maslikova, E. A., Elovskaya, A. A., Nesterova, O. V., Allahverdiyev, A. F., Dikopova, N. Z., Volkov, A. G., Sergeyev, O. V., Velichko, E. V., Maltseva, L. D., & Morozova, O. L. (2026). Oral Health Assessment in Adolescents with End-Stage Chronic Kidney Disease. Journal of Clinical Medicine, 15(1), 165. https://doi.org/10.3390/jcm15010165

